When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CYDY - CytoDyn In Treatment Of COVID-19: The BP Saga
CytoDyn Inc
CytoDyn (CYDY) shareholders experienced a big letdown following its exhilarating, albeit brief, sprint to $10.00 back in late July. Now, one short month later [pun intended], the floor seems to have fallen away. CytoDyn has breached the $3.00 level on several occasions recently.
On Friday, 08/21/20, a slight recovery started. I anticipate that this will continue over the near term. I remain cautiously bullish on CytoDyn's COVID-19 prospects going forward as I will explain in this article. I consider that its downdraft was overdone and that it will likely correct part of the overreaction.